State and private sector insurance officials have favored a compounded version of a drug for high-risk pregnancies over a brand name version. This decision is being questioned in light of the meningitis outbreak from compounded drugs.
Compounding pharmacies should be subject to the same rules as any pharmaceutical manufacturing facility, but the FDA should be able to exempt classes of compounding pharmacies from the rule. FDA would immediately exempt most compounding pharmacies except for the large industrial ones, which is where most of the danger is.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.